Mycophenolate mofetil rescue therapy in liver transplant recipients.
Gavlik
A
A
Department of Surgery, University of Miami School of Medicine, FL 33101-5809, USA.
Goldberg
M G
MG
Tsaroucha
A
A
Webb
M G
MG
Khan
R T
RT
Weppler
D
D
Nery
J R
JR
Khan
M F
MF
Zucker
K
K
Viciana
A L
AL
Miller
J A
JA
Tzakis
A G
AG
D000328:Adult; D002648:Child; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006973:Hypertension; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced; D016031:Liver Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013256:Steroids / Q000009:adverse effects*; D016559:Tacrolimus / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D013256:Steroids; D009173:Mycophenolic Acid; D016559:Tacrolimus